Found 8 matching trials
Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate
PHASE2RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and ei...
Location
Memorial Sloan-Kettering Cancer Center
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
PHASE1The purpose of this study is to evaluate changes in tumor blood flow and di...
Location
Weill Cornell Medical College
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
PHASE2The purpose of this study is to test the effectiveness of the experimental ...
Status
Active Not Recruiting
J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts
PHASE1This clinical trial is for men with advanced prostate cancer that may have ...
Location
Weill Cornell Medical College
Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer
PHASE1The purpose of this study is to define the safety and accuracy of 89Zr-DFO-...
Location
Memorial Sloan-Kettering Cancer Center
Neoadjuvant J591 Treatment for Prostate Cancer
PHASE110 patients will be enrolled in the initial cohort and will receive two inf...
Location
Weill Cornell Medical College
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
PHASE2RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Location
Memorial Sloan-Kettering Cancer Center
Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer
PHASE2The purpose of this study is to find out how effective 177Lu -J591 is in th...
Location
Weill Medcial College of Cornell University